M., Wolf, B., & Gottlieb, A
Regulatory Differences by Administration Route Injectable GHK-Cu Injectable GHK-Cu Copper Tripeptide-1 Powder products have faced stricter regulatory review
Do not apply to sensitive skin types or apply very sparingly (highly diluted) to avoid excess irritation
By targeting the enzyme NNMT (Nicotinamide N-methyltransferase), these peptides help regulate metabolic processes, which can fat metabolism and optimize body composition
Here's how they compare: Peptide Primary research area FDA status Advisory committee review BPC-157 Tissue repair, angiogenesis Not approved Yes (free base + acetate) TB-500 Actin regulation, cell migration Not approved Yes MOTS-c Mitochondrial metabolism Not approved Yes KPV Anti-inflammatory Not approved Yes GHK-Cu Copper-peptide skin/healing Not approved Not on 2026 agenda For a deeper comparison of BPC-157 and its most-researched counterpart, see our BPC-157 vs TB-500 research comparison